Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Flash Player 9.0.0 is required for the Video Gallery.
Get Adobe Flash Player.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
European Hematology Association
HemaSphere. 2(1):e19, January-February 2018
In this video author Sake van der Wall discuss his latest article Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism. And expert Sabine Eichinger explains why she finds this article interesting which resulted in a collaboration between a Dutch and Spanish group.